We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
An FDA advisory committee voted 7-6, with one abstention, that data provided by Sanofi do not support the effectiveness of the drugmaker's dengue vaccine Dengvaxia in patients aged nine to 45 years living in endemic areas who were previously diagnosed wit